A panel of advisers to the US Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
US FDA advisers vote in favor of booster for J&J COVID-19 vaccine
By REUTERS
05/08/2024 02:48 PM
By REUTERS
05/08/2024 01:54 PM
By REUTERS
05/08/2024 12:19 PM
By REUTERS
05/08/2024 11:53 AM
By REUTERS
05/08/2024 10:59 AM
By REUTERS
05/08/2024 10:34 AM
By REUTERS
05/08/2024 09:01 AM
By REUTERS
05/08/2024 08:47 AM
By REUTERS
05/08/2024 06:08 AM